Sector group


Acquiring robust patent protection for chemical and pharmaceutical products and technologies, and possessing a good appreciation of any freedom-to-operate risks, is critically important to these industries.

Image of technician

HGF has one of the largest and most experienced teams of chemistry and pharmaceutical patent attorneys in Europe.  We have over 45 patent professionals located in the UK, Germany, The Netherlands and Switzerland, and collectively we have a diverse blend of high-standard degrees and doctorates in specialist areas.  Many of our attorneys also have extensive in-house experience acquired working for large multi-national companies.

We act for a global client base and cover the full spectrum of chemical technologies, including pharmaceuticals, agrochemicals, food science, cosmetics, household products, materials/metallurgy, petrochemicals, catalysis, polymer chemistry, energy, electrochemistry, printing technologies and physical chemistry.

We have established an enviable reputation in the chemistry and pharmaceutical field and continue to grow our client base, predominately by recommendation.  Working closely with our clients, we devise the optimal IP strategy to achieve the best commercial outcome.  We have extensive experience in the drafting, prosecution and management of world-wide patent portfolios, as well as conducting freedom-to-operate assessments, handling IP due diligence evaluations and oppositions and appeal proceedings before the European Patent Office.  We also have a specialist supplementary protection certificates team for pharmaceutical and agrochemical products. In addition, our chemistry and pharmaceutical attorneys work closely with our IP lawyers in relation to life cycle agreements such as R&D collaborations, companion diagnostics, IP licensing, clinical trials through to commercial manufacturing and supply, and litigation.

Latest updates

UPC moves one step closer to 2022 launch

The Austrian parliament has completed the legislative procedure to ratify the Protocol on the provisional application of the Agreement on a Unified Patent Court (the “Protocol”; see here). When deposited, …

Read article
Event - 9th December 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …

Event details

Next Pro-Chancellor appointed at the University of Leeds

A Leeds alumnus has been appointed as the next Pro-Chancellor of the University of Leeds. A lawyer by background, with a strong track record in leadership in education and social …

Read article